Literature DB >> 19332230

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.

R Graham Barr1, Bartolome R Celli, David M Mannino, Thomas Petty, Stephen I Rennard, Frank C Sciurba, James K Stoller, Byron M Thomashow, Gerard M Turino.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States but is often undertreated. COPD often overlaps with other conditions such as hypertension and osteoporosis, which are less morbid but may be treated more aggressively. We evaluated the prevalence of these comorbid conditions and compared testing, patient knowledge, and management in a national sample of patients with COPD.
METHODS: A survey was administered by telephone in 2006 to 1003 patients with COPD to evaluate the prevalence of comorbid conditions, diagnostic testing, knowledge, and management using standardized instruments. The completion rate was 87%.
RESULTS: Among 1003 patients with COPD, 61% reported moderate or severe dyspnea and 41% reported a prior hospitalization for COPD. The most prevalent comorbid diagnoses were hypertension (55%), hypercholesterolemia (52%), depression (37%), cataracts (31%), and osteoporosis (28%). Only 10% of respondents knew their forced expiratory volume in 1 second (95% confidence interval [CI], 8-12) compared with 79% who knew their blood pressure (95% CI, 76-83). Seventy-two percent (95% CI, 69-75) reported taking any medication for COPD, usually a short-acting bronchodilator, whereas 87% (95% CI, 84-90) of patients with COPD and hypertension were taking an antihypertensive medication and 72% (95% CI, 68-75) of patients with COPD and hypercholesterolemia were taking a statin.
CONCLUSION: Although most patients with COPD in this national sample were symptomatic and many had been hospitalized for COPD, COPD self-knowledge was low and COPD was undertreated compared with generally asymptomatic, less morbid conditions such as hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19332230      PMCID: PMC2692705          DOI: 10.1016/j.amjmed.2008.09.042

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  45 in total

1.  Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey.

Authors:  R Graham Barr; Bartolome R Celli; Fernando J Martinez; Andrew L Ries; Stephen I Rennard; John J Reilly; Frank C Sciurba; Byron M Thomashow; Robert A Wise
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

2.  Co-morbidity in older patients with COPD--its impact on health service utilisation and quality of life, a community study.

Authors:  J Yeo; G Karimova; S Bansal
Journal:  Age Ageing       Date:  2006-01       Impact factor: 10.668

3.  Summary health statistics for the U.S. population: National Health Interview Survey, 2004.

Authors:  Patricia F Adams; Patricia M Barnes
Journal:  Vital Health Stat 10       Date:  2006-08

Review 4.  Prevalence and impact of depression in chronic obstructive pulmonary disease patients.

Authors:  Rachel Norwood
Journal:  Curr Opin Pulm Med       Date:  2006-03       Impact factor: 3.155

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.

Authors:  Douglas W Mapel; David Dedrick; Kourtney Davis
Journal:  COPD       Date:  2005-03       Impact factor: 2.409

7.  Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Authors:  Suellen M Curkendall; Stephan Lanes; Cynthia de Luise; Mary Rose Stang; Judith K Jones; Dewei She; Earl Goehring
Journal:  Eur J Epidemiol       Date:  2006-11-15       Impact factor: 8.082

8.  The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

Authors:  N R Jørgensen; P Schwarz; I Holme; B M Henriksen; L J Petersen; V Backer
Journal:  Respir Med       Date:  2006-05-04       Impact factor: 3.415

9.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

Review 10.  Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.

Authors:  R G Barr; J Bourbeau; C A Camargo; F S F Ram
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

View more
  72 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

2.  Concordance of patients' beliefs about chronic obstructive pulmonary disease, their comorbidities, and their medications.

Authors:  Grace E McInerney; Kimberly Muellers; Rachel O'Conor; Michael S Wolf; Howard Leventhal; Juan P Wisnivesky; Alex D Federman
Journal:  Patient Educ Couns       Date:  2019-11-16

3.  Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction.

Authors:  Josiah E Radder; Yingze Zhang; Alyssa D Gregory; Shibing Yu; Neil J Kelly; Joseph K Leader; Naftali Kaminski; Frank C Sciurba; Steven D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

4.  A Basic Question: Are Patients with Chronic Obstructive Pulmonary Disease Aware of Their Disease?

Authors:  Fatma Işıl Uzel; Pelin Karadağ; Seda Tural Önür; Demet Turan; Esin Yentürk; Esin Tuncay
Journal:  Turk Thorac J       Date:  2017-10-01

Review 5.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

Review 6.  The effect of pulmonary rehabilitation on mortality, balance, and risk of fall in stable patients with chronic obstructive pulmonary disease.

Authors:  Ali Hakamy; Charlotte E Bolton; Tricia M McKeever
Journal:  Chron Respir Dis       Date:  2016-01-01       Impact factor: 2.444

7.  Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Patricia Langenberg; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Michael Terrin
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

Review 8.  The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.

Authors:  Barbara P Yawn; Ibrahim Raphiou; Judith S Hurley; Anand A Dalal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

Review 9.  Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.

Authors:  Christopher M Blanchette; Nicholas J Gross; Pablo Altman
Journal:  Am Health Drug Benefits       Date:  2014-04

10.  Analytic Hierarchy Process to Define the Most Important Factors and Related Technologies for Empowering Elderly People in Taking an Active Role in their Health.

Authors:  G Fico; E Gaeta; M T Arredondo; L Pecchia
Journal:  J Med Syst       Date:  2015-08-08       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.